| High energy transurethral microwave thermotherapy for benign prostatic hyperplasia. Assessment report. |
| Author(s): Medicare Services Advisory Committee (MSAC). |
| Affiliations(s): |
| Publication(s): Department of Health and Ageing, Commonwealth of Australia. Canberra. |
| Document Type(s): Manuscript in preparation |
| Countries: Australia |
C:
Y: |
Oncology
2006 |
|
L:
A: |
English
|
|
 |
| |
| |
| Long term clinical effect of an HPV-vaccine for the prevention of cervical cancer in France in relation to age of vaccination: Results from a markov model |
| Author(s): Demarteau N, Detournay B, El Hansnaoui A Standaert B, Annemans L |
| Affiliations(s): |
| Publication(s): |
| Document Type(s): Poster |
| Countries: France |
C:
Y: |
Oncology
2006 |
|
L:
A: |
English
|
|
|
| |
| |
| Erlotinib in non-small cell lung cancer (NSCLC) in Germany - A cost-saving second-line treatment option? |
| Author(s): Gabriel A1, Pirk O1, Kotowa W1 |
| Affiliations(s): 1 IMS Health, Nuremberg, Germany |
| Publication(s): Value in Health 2006, 9(6): A278 |
| Document Type(s): Abstract, Oral presentation |
| Countries: Germany |
C:
Y: |
Oncology
2006 |
|
L:
A: |
English
Cost minimization |
|
|
| |
| |
| Costs of chemotherapy for indolent follicular nonHodgkin’s lymphoma in the UK: an observational study. |
| Author(s): Hutchinson J1, Lloyd A1, Gray A2, Gale R3, Hancock B4. |
| Affiliations(s): 1 Fourth Hurdle Consulting, London, UK 2 Health Economics Research Centre, Oxford University, Oxford UK 3 Schering Health Care, West Sussex, UK 4 School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK |
| Publication(s): Acta Haematol. 2006;115(1-2):28-34. |
| Document Type(s): Manuscript in preparation |
| Countries: UK |
C:
Y: |
Oncology
2006 |
|
L:
A: |
English
Cost of illness |
|
|
| |
| |
| Patient preference and willingnesss-to-pay for pemetrexed versus docetaxel in the Patient preference and willingnesss-to-pay for pemetrexed versus docetaxel in the second-line treatment of advanced non-small cell lung cancer: a discrete choice conjoint analysis |
| Author(s): Brown A, Aristides M, FitzGerald P, Liepa A, Boyer M, Clarke S |
| Affiliations(s): |
| Publication(s): ISPOR 2nd Asia-Pacific conference |
| Document Type(s): Poster |
| Countries: |
C:
Y: |
Oncology
2006 |
|
L:
A: |
English
Willingness to pay |
|
|
| |
| |
| Validity of tests for initial diagnosis and its concordance with final diagnosis in patients with suspected benign prostatic hyperplasia |
| Author(s): Carballido J, Badia X, Gimeno A, Regadera L, Dal-Ré L, Guilera M |
| Affiliations(s): |
| Publication(s): Actas Urol Esp 2006;30(7):667-4 |
| Document Type(s): Article |
| Countries: Spain |
C:
Y: |
Oncology
2006 |
|
L:
A: |
Spanish
Quality of life |
|
|
| |
| |
| Adjuvant trastuzumab treatment in early stage breast cancer: cost-effectiveness in the Belgian healthcare setting. |
| Author(s): Van Vlaenderen I, Canon JL, Cocquyt V, Jerusalem G, Machiels JP, Neven P, Nechelput M, Delabaye I, Gyldmark M, Annemans L |
| Affiliations(s): |
| Publication(s): Value in Health, 10(6): A336 |
| Document Type(s): Oral presentation |
| Countries: Belgium |
C:
Y: |
Oncology
2006 |
|
L:
A: |
English
Cost utility |
|
|
| |
| |
| Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany. |
| Author(s): Lordick F 1, Ehlken B 2, Ihbe-Heffinger A 3, Berger K 2, Krobot KJ 4, Pellissier J 5, Davies G 5, Deuson R 6. |
| Affiliations(s): 1 Third Medical Department, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
2 IMS Health, Munich, Germany
3 Dept. of Pharmacy, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
4 Outcomes Research, MSD Sharp & Dohme GmbH, Haar, Germany
5 Health Economic Statistics, Merck & Co. Inc., 10 Sentry Pkwy, Blue Bell, USA
6 Outcomes Research, Merck & Co. Inc., One Merck Drive, Whitehouse Station, NJ, USA |
| Publication(s): Eur J Cancer 2007; 43(2): 299-307 |
| Document Type(s): Article |
| Countries: Germany |
C:
Y: |
Oncology
2006 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
 42 of 42
|
